Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Hodgkin Disease 1Graft vs Host Disease 1Bronchiolitis Obliterans Syndrome 1

Interventions

Cyclophosphamide 5Mycophenolic Acid 4Sirolimus 3fludarabine phosphate 2Whole-Body Irradiation 2Tacrolimus 2Methotrexate 2Melphalan 2Cyclosporine 2Busulfan 2vedolizumab 1ruxolitinib 1ibrutinib 1fludarabine 1baricitinib 1axatilimab 1Vorinostat 1Peripheral Blood Stem Cell Transplantation 1Panobinostat 1Etoposide 1Blood Specimen Collection 1Abatacept 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Graft vs Host Disease × axatilimab × Clear all
NCT04710576 2026-03-16

AGAVE-201

Syndax Pharmaceuticals

Phase 2 Active not recruiting
241 enrolled 11 charts 1 FDA

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡